Analyst Ratings Network.com reported that Boston Scientific has received a consensus rating of "buy" from 24 research firms, according to WKRB News & Analysis.
Here are four key notes:
1. Boston Scientific has a 52-week low of $11.10 and a 52-week high of $18.62.
2. The average 12-month price objective among brokerages, which updated their coverage on the stock in the last year, is $19.03.
3. Boston Scientific's 50-day moving average is $17.55 and its 200-day moving average is $17.29.
4. The company's market capitalization is $23.61 billion.